OPERON ELEVATEPLUS | REGULATORY DUE DILIGENCE FOR MEDICAL DEVICES

Regulatory Due Diligence Services for Medical Devices in Oman

Operon Strategist delivers structured Regulatory Due Diligence services that provide clear visibility into regulatory status, compliance maturity, approval dependencies, and hidden risks. Our assessments go beyond checklists, offering decision-grade intelligence that supports confident investment decisions, deal structuring, and post-transaction planning.

Take the next step

Connect with our experts to discuss your next big medical device idea
Contact Us

Operon ElevatePlus
Regulatory Due Diligence for Medical Devices Service Portfolio

Validation of device classification and intended use

Review of current and planned regulatory approval routes

Assessment of submission, approval, and commitment status

Identification of approval dependencies impacting deal timelines

Markets covered: US FDA, EU MDR/IVDR, UKCA, CDSCO, SFDA, and other global jurisdictions

Evaluation of technical documentation and dossier completeness

ISO 13485 and Quality Management System compliance assessment

Review of labeling, IFU, claims, and promotional compliance risks

Assessment of Post-Market Surveillance and vigilance obligations

Review of manufacturing licenses and site authorizations

QMS maturity assessment against certification scope

Inspection readiness analysis (FDA, Notified Body, CDSCO)

Review of audit observations, CAPAs, and open nonconformities

Identification of process validation and production control risks

Identification of comparable approved devices

Review of substantial equivalence and regulatory precedents

Competitive regulatory positioning and approval learnings

Review of clinical, performance, usability, and real-world data

Alignment with FDA, EU MDR/IVDR, and global evidence expectations

Identification of evidence gaps and post-market study risks

Classification of risks as critical, major, or manageablerformance, usability, and real-world data

Identification of regulatory non-compliance exposure

Approval dependency and enforcement risk evaluation

Estimation of remediation effort, cost, and timeline

What Sets Us Apart

Global exposure, structured thinking, and execution-ready expertise

Global Regulatory Expertise Across US, EU, UK, India, GCC & Emerging Markets

Coverage of Medical Devices & IVDs Across All Risk Classes

Experience Supporting Investment, M&A & Strategic Transactions

Proven Insights Aligned with Real-World Approvals & Inspections

Regulatory due diligence for medical device investments and transactions – we support investors and companies with comprehensive regulatory due diligence to assess compliance risks and market readiness. Each engagement includes a detailed due diligence report covering risk classification, market-wise regulatory status, approval pathways, and the impact of regulatory risks on valuation and transaction timelines, along with clear pre-close and post-close regulatory action plans.

Operon Regulatory Due Diligence for Medical Devices Advantage

Identify regulatory risks, approval gaps, and compliance exposure before you invest, acquire, license, or partner-through expert, decisiongrade regulatory due diligence

Independent, Execution-Neutral Regulatory Assessments

Translation of Regulatory Exposure into Business & Valuation Impact

Market-Wise, Approval-Focused Risk Visibility

Practical Remediation & Post-Transaction Planning Insights

You Might Also Be Interested in

Design History File (DHF)

CE Marking

UKCA Marking

US FDA (510(k), QMSR & Registration)

SFDA (Saudi Arabia) Registration

CDSCO (India)

Drug–Device Combination Product Documentation

Veterinary Medical Devices Registration

BIS Certification

Quality Management System (QMS)

frequently asked questions

Regulatory due diligence is typically conducted during M&A transactions, private equity investments, licensing agreements, or partnership evaluations to uncover hidden compliance risks before deal closure.

Operon Strategist’s due diligence reports cover regulatory pathway status, classification validation, QMS and documentation review, manufacturing compliance, predicate analysis, clinical evidence gaps, and risk classification with remediation recommendations.

Regulatory due diligence translates compliance gaps, approval dependencies, and inspection risks into business impact, helping investors and acquirers adjust valuation, structure deal terms, and plan post-transaction remediation.

Yes, Operon Strategist provides both pre-close risk assessment and post-close regulatory action plans to help companies address compliance gaps identified during due diligence.

Identify Regulatory Risks Before You Invest, Acquire, or Partner

Talk to a regulatory due diligence expert

Please provide the following information and we’ll put you in touch with the right person.